MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
Journal Article

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

2003
Request Book From Autostore and Choose the Collection Method
Overview
ChimeriVax-JE is a live, attenuated vaccine against Japanese encephalitis, using yellow fever (YF) 17D vaccine as a vector. In a double-blind phase 2 trial, 99 adults received vaccine, placebo, or YF 17D vaccine (YF-VAX). ChimeriVax-JE was well tolerated, with no differences in adverse events between treatment groups. Viremias resulting from administration of ChimeriVax-JE and YF-VAX were of short duration and low titer; 82 (94%) of 87 subjects administered graded doses (1.8–5.8 log10) of ChimeriVax-JE developed neutralizing antibodies. A second dose, administered 30 days later, had no booster effect. Previous inoculation with YF did not interfere with ChimeriVax-JE, but there was a suggestion (not statistically significant) that ChimeriVax-JE interfered with YF-VAX administered 30 days later. A separate study explored immunological memory both in subjects who had received ChimeriVax-JE 9 months before and in ChimeriVax-JE–naive subjects challenged with inactivated mouse-brain vaccine (JE-VAX). Anamnestic responses were observed in preimmune individuals. ChimeriVax-JE appears to be a safe vaccine that provides protective levels of neutralizing antibody after a single dose
Publisher
The University of Chicago Press,University of Chicago Press,Oxford University Press
Subject

Animals

/ Antibodies

/ Antibodies, Viral - blood

/ Antigens, Viral - immunology

/ Applied microbiology

/ Arboviral encephalitis

/ Arboviroses

/ Biological and medical sciences

/ Dosage

/ Dose-Response Relationship, Drug

/ Double-Blind Method

/ Encephalitis Virus, Japanese - genetics

/ Encephalitis Virus, Japanese - immunology

/ Encephalitis, Japanese - prevention & control

/ Encephalitis, Japanese - virology

/ Fundamental and applied biological sciences. Psychology

/ Genetic Vectors

/ HIV/AIDS

/ Human viral diseases

/ Humans

/ Immunization Schedule

/ Immunologic Memory

/ Infectious diseases

/ Inoculation

/ Japanese encephalitis

/ Japanese Encephalitis Vaccines - administration & dosage

/ Japanese Encephalitis Vaccines - adverse effects

/ Japanese Encephalitis Vaccines - immunology

/ Medical sciences

/ Mice

/ Microbiology

/ Neutralization Tests

/ Neutralizing antibodies

/ Placebos

/ Treatment Outcome

/ Tropical viral diseases

/ Vaccination

/ Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)

/ Vaccines, Attenuated - administration & dosage

/ Vaccines, Attenuated - adverse effects

/ Vaccines, Attenuated - immunology

/ Vaccines, Inactivated

/ Viral diseases

/ Viral Vaccines - administration & dosage

/ Viral Vaccines - adverse effects

/ Viral Vaccines - genetics

/ Viral Vaccines - immunology

/ Viremia

/ Viruses

/ West Nile Virus Vaccines

/ Yellow fever

/ Yellow Fever Vaccine - administration & dosage

/ Yellow Fever Vaccine - adverse effects

/ Yellow Fever Vaccine - genetics

/ Yellow Fever Vaccine - immunology

/ Yellow fever virus - genetics